Tight Blood Sugar Control Boosts Brain Power of Teens With Type 1 Diabetes: Study
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — When teenagers with type 1 diabetes get better control of their blood sugar, their brains may benefit, a new clinical trial shows.Researchers found that when teenagers started treatment with a newer technol…
Learn MoreShort Menstrual Cycles Tied to More Symptoms at Menopause
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Women with short menstrual cycles (≤25 days) during reproductive years appear to have a higher frequency of total menopausal symptoms and an earlier age of natural menopause, according to a study published …
Learn MoreRisk for Neonatal Opioid Withdrawal Syndrome Examined
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Neonates exposed to strong agonists and long half-life prescription opioids in the third trimester of pregnancy have an increased risk for neonatal opioid withdrawal syndrome (NOWS), according to a study pu…
Learn MoreUblituximab Bests Teriflunomide in Relapsing Multiple Sclerosis
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Patients with relapsing multiple sclerosis receiving ublituximab have lower annualized relapse rates and fewer brain lesions on magnetic resonance imaging than those receiving teriflunomide, according to a …
Learn MoreMultiple Chemical Sensitivity ID’d in Some Migraine Patients
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — One in five migraine patients has multiple chemical sensitivity (MCS), according to a study recently published in the Journal of Occupational Health.
Keisuke Suzuki, M.D., Ph.D., from Dokkyo Medical Uni…
Learn MoreLong-Term Outcomes of ThuLEP Reported for Benign Prostatic Enlargement
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — The 12-year experience with thulium laser enucleation of the prostate (ThuLEP) for benign prostatic enlargement (BPE) at one tertiary referral center shows low rates of repeat treatment for recurrence or …
Learn MoreFDA Approves Omicron-Specific Booster Shots From Pfizer, Moderna
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Wednesday gave the green light to updated COVID booster shots from both Pfizer and Moderna that target Omicron variants, paving the way for the shots to get into Ame…
Learn MoreEfforts to Preserve Fertility Won’t Affect Breast Cancer Outcomes
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Fertility preservation procedures for women with breast cancer won’t raise the risk of their cancer returning later, a new Swedish study shows.Women who had eggs or embryos frozen before going through chemo…
Learn More